{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:11:14Z","timestamp":1773965474727,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T00:00:00Z","timestamp":1405296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00467-014-2874-8","type":"journal-article","created":{"date-parts":[[2014,7,13]],"date-time":"2014-07-13T11:49:38Z","timestamp":1405252178000},"page":"2333-2340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Minimal change disease: a dysregulation of the podocyte CD80\u2013CTLA-4 axis?"],"prefix":"10.1007","volume":"29","author":[{"given":"Gabriel","family":"Cara-Fuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive H.","family":"Wasserfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo H.","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,14]]},"reference":[{"key":"2874_CR1","first-page":"209","volume-title":"Comprehensive clinical nephrology","author":"J Feehally","year":"2007","unstructured":"Feehally J, Floege J, Johnson RJ (2007) Comprehensive clinical nephrology, 3rd edn. Mosby Elsevier, Philadephia, pp 209\u2013216","edition":"3"},{"key":"2874_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1440-1754.2004.00285.x","volume":"40","author":"RK Alwadhi","year":"2004","unstructured":"Alwadhi RK, Mathew JL, Rath B (2004) Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health 40:28\u201332","journal-title":"J Paediatr Child Health"},{"key":"2874_CR3","volume-title":"Treatment of primary glomerulonephritis","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Glassock RJ (2010) Treatment of primary glomerulonephritis, 2nd edn. Oxford University Press, New York","edition":"2"},{"key":"2874_CR4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2215\/CJN.04121206","volume":"2","author":"L Barisoni","year":"2007","unstructured":"Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2:529\u2013542","journal-title":"Clin J Am Soc Nephrol"},{"key":"2874_CR5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78:296\u2013302","journal-title":"Kidney Int"},{"key":"2874_CR6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","volume":"20","author":"EH Garin","year":"2009","unstructured":"Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20:260\u2013266","journal-title":"J Am Soc Nephrol"},{"key":"2874_CR7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/ndt\/gfs543","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, Lanaspa MA, Rivard C, Maruyama S, Garin EH, Johnson RJ (2013) Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant 28:1439\u20131446","journal-title":"Nephrol Dial Transplant"},{"key":"2874_CR8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271\u2013275","journal-title":"Science"},{"key":"2874_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","volume":"26","author":"M Shimada","year":"2011","unstructured":"Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a \u201cTwo hit\u201d podocyte immune disorder? Pediatr Nephrol 26:645\u2013649","journal-title":"Pediatr Nephrol"},{"key":"2874_CR10","doi-asserted-by":"crossref","unstructured":"Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of kidney Disease in Children. Lancet 760:1299\u20131302","DOI":"10.1016\/S0140-6736(70)91905-7"},{"key":"2874_CR11","doi-asserted-by":"crossref","unstructured":"[No authors cited] (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20:765\u2013771","DOI":"10.1038\/ki.1981.209"},{"key":"2874_CR12","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.164.10.5015","volume":"164","author":"MK Oaks","year":"2000","unstructured":"Oaks MK, Hallet KM (2000) Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015\u20135018","journal-title":"J Immunol"},{"key":"2874_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116\u2013126","journal-title":"Nat Rev Immunol"},{"key":"2874_CR14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1159\/000064084","volume":"92","author":"U Niemann-Masanek","year":"2002","unstructured":"Niemann-Masanek U, Mueller A, Yard BA, Waldherr R, van der Woude FJ (2002) B7\u20131 (CD80) and B7\u20132 (CD86) expression in human tubular epithelial cells in vivo and in vitro. Nephron 92:542\u2013556","journal-title":"Nephron"},{"key":"2874_CR15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390\u20131397","journal-title":"J Clin Invest"},{"key":"2874_CR16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s000180050403","volume":"55","author":"M Xia","year":"1999","unstructured":"Xia M, Gasser J, Feige U (1999) Dexamethasone enhances CTLA-4 expression during T cell activation. Cell Mol Life Sci 55:1649\u20131656","journal-title":"Cell Mol Life Sci"},{"key":"2874_CR17","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/ndt\/gft381","volume":"28","author":"C Spink","year":"2013","unstructured":"Spink C, Stege G, Tenbrock K, Harendza S (2013) The CTLA-4\u2009+\u200949GG genotype is associated with susceptibility for nephrotic kidney diseases. Nephrol Dial Transplant 28:2800\u20132805","journal-title":"Nephrol Dial Transplant"},{"key":"2874_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/annrheumdis-2013-203843","volume":"73","author":"M Schiff","year":"2014","unstructured":"Schiff M, Weinblatt ME, Valente R, van der Heijde D, Citera G, Elegbe A, Maldonado M, Fleischmann R (2014) Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Ann Rheum Dis 73:86\u201394","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2874-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2874-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2874-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:07:04Z","timestamp":1559092024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2874-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,14]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2874"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2874-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,14]]}}}